Evvy Secures $40M to Advance Women's Health Through Vaginal Microbiome Data

Evvy has successfully raised $40 million in new funding. The capital will be used to further women's health research. A primary focus of Evvy has successfully raised $40 million in new funding. The capital will be used to further women's health research. A primary focus of

the research involves vaginal microbiome data. The company was founded by women aiming to close gaps in care. Vaginal microbiome analysis is central to the platform's offering. The funding round supports expansion of these scientific efforts. This investment highlights

growing interest in female-focused healthcare. Further details on product rollouts will follow.